TransCode Therapeutics Announces Closing of $7.25 Million Public Offering
January 22, 2024 16:45 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics closes public offering
TransCode Therapeutics To Participate at H.C. Wainwright BioConnect Conference
January 06, 2022 15:17 ET
|
TransCode Therapeutics, Inc.
BOSTON, Jan. 06, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that it will be attending and presenting at the H.C. Wainwright BioConnect Conference....